SERVICES
R&D, product development and regulatory consulting for small and mid-sized CPG companies.
Three ways we create value from your R&D.
We pair R&D, regulatory and innovation expertise, proven at Procter & Gamble, with state-of-the-art virtual tools to close the GAP between your R&D and its hidden value.
Most R&D challenges fall into one of three areas. Select the one that sounds most like yours.
Grow · Accelerate · Protect
Grow: CPG product innovation, brand renewal and new product development
Without big budgets, seasoned teams and the right tools, many companies leave their most profitable opportunities untapped, with real growth locked inside assets they already own.
Problems we solve
Hero products losing relevance or their distinctive benefits
Failing product ratings, repeat purchase or efficacy perceptions
Competitors delivering better performance or stronger claims
Products that no longer meet consumer expectations or evolving standards
Flat revenue, margins or market share, with no clear next opportunity
Technology and IP that are not earning their full value
What we do
We find the non-obvious growth already inside your brands, technology and IP.
Brand and product renewal: Rebuild the performance, benefits and claims that drive ratings and repeat purchase
New opportunities: Identify the claims, products and adjacent markets your brand equity can support
Technology: Find new uses for existing technologies and uncover non-obvious ingredients or formulae using state-of-the-art tools
IP: Uncover under-used IP and know-how, including licensing opportunities, and align your patent portfolio with commercial priorities
Growth plan: Prioritize opportunities by ROI, feasibility, timing and risk
What you get
A credible plan, grounded in what you already own, to grow revenue, margins, EBITDA and market share.
Accelerate: Faster product development, outsourced R&D and fractional R&D leadership
Projects stall when the problem is poorly defined, regulatory needs surface late, the development process moves too slowly, and teams lack the capabilities and capacity to keep up.
Problems we solve
Slow product development cycles, stalled launches and delayed commercial results
Technical or regulatory issues discovered late
Formula drift and batch variability
Stability problems and formula-packaging compatibility or performance issues
Technical testing, consumer validation or new ingredients holding up launch
Too little R&D capacity or missing critical expertise
What we do
We remove the barriers between opportunity and launch, so you get to market faster.
Pipeline: Diagnose what's slowing development, and fix it
Technical problem-solving: Resolve formula drift, batch variability, stability and packaging compatibility problems
Testing and validation: Plan technical testing, consumer validation and new ingredient work so they support launch instead of delaying it
Fractional R&D leadership: Add senior R&D or regulatory leadership and capacity on a fractional or interim basis
Senior judgment: Bring technical, regulatory and commercialization experience to key decisions
AI and modeling: Apply them only where they shorten timelines and pay off
Partners: Strengthen how you work with suppliers, contract manufacturers and testing partners
What you get
Faster, more confident, lower-risk decisions, shorter development timelines and a quicker path from idea to revenue.
Protect: Regulatory consulting, FDA compliance, claims, cost and IP protection
Your products face risks you may not control today but can tomorrow: restricted ingredients, retailer requirements, FDA action, challenged claims, IP constraints, rising costs and R&D spend that does not pay back.
Problems we solve
FDA and labels: MoCRA compliance gaps, label compliance issues and label fixes, FDA warning letters, or missing regulatory due diligence for cosmetics, OTC drugs and dietary supplements
Claims: Insufficient substantiation for efficacy, clinical, performance, environmental or comparative claims, and competitor claim challenges
IP: Freedom-to-operate or potential infringement concerns discovered too late, new whitespace opportunities
Cost: Cost pressures including the need to reduce formula costs or overheads without losing quality
Wasted R&D: R&D spend not producing returns, projects prioritized by organizational preference rather than consumer need, and technical work that starts before the most profitable consumer problem or the success criteria are defined
Product performance: Performance failures, product complaints and adverse consumer experiences
R&D program risk: Technical, regulatory, supplier or timeline risks that could derail a program, especially when they surface after major investment
What we do
We safeguard your products, IP and R&D investments, and stop costly missteps before they happen, to protect your brand equity and reputation.
Portfolio risk: Assess regulatory and retailer exposure before it becomes urgent
FDA compliance: Guide cosmetics through MoCRA, and OTC drugs and dietary supplements through FDA requirements
Labels and enforcement: Fix label issues before launch or after a problem is found, and respond to FDA action, including warning letters
Regulatory path and claims: Plan testing and substantiation early, so it's done once
Claims defense: Defend your claims or challenge a competitor's, including NAD advertising challenges
Reformulation: Build substitution strategies that protect performance and brand equity, and reduce costs without sacrificing quality
Product performance: Find the root cause of failures and complaints, and fix them
R&D focus: Define the critical problem first with our Critical Problem Definition™ approach, set the technical model and success criteria, then use virtual screening and modeling to decide what to continue, redirect or stop
IP: Review protection on your key technologies and formulas, and surface freedom-to-operate concerns early
What you get
A clear view of your risks, fewer costly surprises, lower costs, and R&D spend directed where it will earn the greatest return.
HOW WE WORK
Relentless curiosity, active listening and hands-on delivery.
We answer to you. Your goals, your priorities, your timeline. The client is our “boss”.
You work directly with the partners. No junior team, no handoffs.
We start with the problem, the value and the risk, before any solution is chosen or money is committed.
We measure success in business terms: revenue, margin, speed to market, protected investment and cost avoided.
We apply AI only where it pays. When AI can materially improve the economics, we help you use it. When it cannot, we won’t.
For private equity firms
Do you own a CPG business with R&D at its core? We give deal teams and operating partners senior R&D and regulatory judgment, without adding headcount.
R&D, regulatory and IP due diligence before you acquire
Pipeline and portfolio assessment for portfolio companies
Value-creation plans grounded in the brands, technology and IP the business already owns